| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -6.8e-05 | 1 |